Understanding Efficacy of Azacitidine in Different MDS Subgroups 

Earn CME for related activities: www.naccme.com...
Filmed on location in Zagreb, Croatia during the European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes from 24-26 April 2015, this webcast is part of a series that focuses on current practices, management approaches, and emerging treatment options.
In this presentation, Dr. Valeria Santini expounds upon how to understand the efficacy of azacitidine in different myelodysplastic syndromes' (MDS) subgroups.
© 2015 Imedex, LLC.